S33T (p.Ser33Thr) variant of CTNNB1 (Catenin beta-1)

S33T (p.Ser33Thr) in CTNNB1 (Catenin beta-1) is a missense change. Clinical records from EBI and UniProt describe it as likely pathogenic in the context of in colorectal cancer and PTR. The available variant effect predictions contribute to a CATVariant prioritization score of 0.49 / 1. The record also includes structural context.

S33T (p.Ser33Thr) variant details